On Demand Webinars
-
Plasmid DNA Downstream Purification Process
4/11/2023
Large scale production of plasmid DNA requires an in-depth understanding and optimization of the entire downstream process. Explore a complete solution, from harvest to bulk filtration.
-
How To Bring (Any) mRNA To Life: Simplifying Nucleic Acid Encapsulation
5/6/2024
New technologies for the encapsulation of nucleic acids, such as FDmiX, can potentially overcome limitations of currently available standard mixing technologies.
-
Accelerate Process Development With HTS Chromatography Tools
7/16/2024
High Throughput Screening (HTS) chromatography tools can accelerate process development and reduce material usage. However, their use is less common in some modalities due to sample restrictions and the need for HTS expertise.
-
Addressing Industry Challenges In mRNA Product Commercialization
While the speed of production and flexibility of mRNA are appealing, several industry challenges must still be addressed to realize the full potential and further expand its use.
-
Building An Effective CCS For Sterile Filtration
6/20/2023
What are the regulatory expectations for sterile filtration throughout product development, how do these feed into the CSS, and how do end-user and supplier responsibilities support Annex 1 compliance?
-
End-To-End Cold Chain Management: A Next-Generation Approach
2/26/2024
Three experts in cold chain management walk through the advantages of end-to-end platforms for bulk drug substance management.
-
The Increasing Demand For Sterile Filtration Of High Concentration Drugs
3/21/2024
Explore the current trends and challenges with manufacturing high-concentration drug products and an approach to performing extensive filterability trials without a high quantity of expensive product.
-
How A Sponsored CMC Platform Accelerates mRNA Projects Into The Clinic
1/31/2023
Developing a client-sponsored Target Product Profile (TPP) and Analytical Target Profile (ATP) is critical to move your drug product to clinic efficiently and meet acceptance criteria.
-
Translation Of RNA Nanomedicines From Design To Clinical
4/14/2022
mRNA therapeutics are applicable to cancer immunotherapies, infectious diseases, and other indications that require protein replacement therapy or antibodies.
-
How mRNA Manufacturers Disrupt The Industry
3/21/2023
Learn how biopharmaceutical companies can apply proven strategies to overcome hidden complexities in mRNA production, and discover solutions that can help you rapidly design and build a SU facility.